Wolverine Trading, LLC Fulcrum Therapeutics, Inc. Put Options Transaction History

Wolverine Trading, LLC

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$3.18 - $9.74 $13,674 - $41,882	4,300 Added 33.86%	17,000 $60,000
Q2 2024 Aug 14, 2024	BUY	$5.98 - $9.31 $75,946 - $118,237	12,700 New	12,700 $78,000
Q2 2022 Aug 15, 2022	BUY	$4.2 - $24.0 $57,540 - $328,800	13,700 New	13,700 $68,000
Q4 2021 Feb 14, 2022	SELL	$14.0 - $28.44 $344,400 - $699,624	-24,600 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$7.28 - $30.97 $179,088 - $761,862	24,600 New	24,600 $684,000

137

55M

886K

93.3K

Ticker FULC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,038,900
Market Cap $451M
Description
Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its product candidates are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystro...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.